Cat retweeted
What would it take to reverse 10-20 years of age-related decline in muscle, cognition and immunity?
#XPRIZE is spending $101 million to try and find out.
Cat retweeted
Over the past few months, I've been collaborating with @socialcapital (@chamath's investment vehicle) on a two-part deep dive into the current state of Longevity Biotech and Aging Research. This deep dive aims to be a solid introduction to the field. It assumes no background in biology, medicine, or biotech.
If you've been wondering what science knows about aging, what makes us believe aging can be slowed or reversed, or which companies are making real progress toward developing therapies against aging, this is for you!
Part 1 is out now. It's a foundation for understanding the biology of aging and the current state of longevity biotech.
Part 2 follows shortly, covering the strategies researchers, companies, and investors are pursuing to slow or reverse aging.
Thank you, @chamath and @socialcapital team, for the opportunity to work with you on it. And thank you to all contributors who helped to make this deep dive objective and engaging, and who are making anti-aging interventions a reality: @Andrei_Tarkhov, @elimohamad, @fedichev, @KarlPfleger, @MarkHamalainen, @MartinBJensen, @MaxUnfried, @mkaeberlein, @omri_drory, @RaianyRomanni, @realnathancheng, @sebastiangiwa, @shappiron, @shoylev, @statto, @strygah, @ydeigin
If any errors are to be found in this deep dive, I own them.
1/ How long do you want to live?
For most of human history, aging was inevitable.
It's now solvable.
Apply for LBF8 cohort program: longbiofellowship dot org
/THREAD🧵
Cat retweeted
NEW: Biotech startup R3 Bio has a bold idea for replacing lab animals: genetically-engineered 'organ sacks' that lack a brain.
The long-term goal? Human versions.
wired.com/story/a-billionair…
Cat retweeted
1/ 🧵Announcing CORHORT 6 of the Longevity Biotech Fellowship —the most hardcore community of longevity accelerationists! Join 700 members working to SOLVE aging entirely.
⌛️Deadline: Mar 14
Kickoff Retreat: Mar 31 - Apr 4 in Berkeley.
👉Apply: longbiofellowship.org/apply
Cat retweeted
VDP 154: Designate VitaDAO as Vitalist Organization 🧬 proposal is live on Snapshot and you can vote with your VITA tokens!
Align with Vitalist Declaration:
1️⃣ Life good, death bad
2️⃣ Aging causes suffering; ending it possible
3️⃣ Mobilize resources to end aging ASAP
4️⃣ Support unlimited healthy lifespan
5️⃣ Spread anti-aging message
More about Vitalism: vitalism.io/vitalist-declara…
🗳️Cast your vote: snapshot.org/#/vote.vitadao.…
Cat retweeted
🚀Super excited to share results from our joint study w/ @OcampoLab showing brain-specific partial reprogramming ameliorating cognitive decline. More evidence for the CNS potential of reprogramming, as we saw in Alzheimer's previously! (as did Altos Labs)
prnewswire.com/news-releases…
Cat retweeted
1/ Vitalism Foundation is co-hosting Tokyo Longevity Summit, the premiere longevity science and startup conference in Japan!
On July 26, join entrepreneurs, researchers, and leaders from around the world building the longevity revolution.
Tickets: tokyolongevitysummit.com/
Cat retweeted
I think this new podcast series is likely to be one of the most unmissable in the field. Check it out.
Replying to @peterottsjo
Cat retweeted
LBF4 was a huge success! Thanks to our hosts (@ClaraFPorta & @JC2go) new cohort, alumni, sponsors, volunteers, & especially our "camp counselors"! @Nst_Egorova @emilkendziorra @ydeigin @aocampox @LinusPeters @strygah @longevion @DanilaImmortal @roland_graser @catthu & many more
Cat retweeted
1/ Is there a credible plan to solve aging in our lifetimes?
A plausible series of steps from where we are today, to a post-aging future?
We looked, but we couldn’t find one. So we decided to build one.
↗️ See V1 of the Roadmap: longbiofellowship.org/roadma…
Cat retweeted
The aging field doesn't discuss enough the key top-level distinction between the 2 main therapeutic paradigms: slow aging or reverse it. I support slowing aging as much better than traditional medicine, but it pains me to see many in the field disparage or ignore reversal & I think there should be more open discussion of this distinction.
Aging is a slow progressive set of molecular changes. The differences between slowing it vs undoing it have important implications that aren't acknowledged enough. Many slow-aging therapies slow most/all the changes w/ 1 approach. In contrast, rejuvenation is necessarily a piecemeal approach of reverting each change to a younger state. Most such interventions undo only 1 type of change, possibly only for 1 type of cell/tissue/organ/system.
Slowing aging is easier. 1 intervention started early can meaningfully extend lifespan. Lifestyle alone controls rate-of-aging by up to ~25% in humans & CR alone by more in shorter-lived species. A single gene mutation famously extends nematode lifespan 10x. Many molecules by themselves extend model species lifespans significantly. Lifespan or healthspan extension are valid ways to judge progress of this strategy, and aging clocks may soon be reasonable substitutes for long-lived species.
Rejuvenation progress is harder for a few reasons. Reverting a single aging change can provide health benefits but is unlikely to extend lifespan much due to all the other changes. Progress for this paradigm depends on both improving the processes of reversing each change but also on adding more of them to cover more changes. Some aging changes are causally pathological but others are likely compensatory, so choosing which to revert is vital. (Some label the changes that need to be reversed damage & the process of reverting them repair.) Many but not all of the changes underlying aging are understood at least partially by now & progress here continues but the fact that all the types may not be fully understood yet is another difficulty for this paradigm. Progress of this paradigm is harder to judge, but there clearly is some.
Also, there are structural incentives that favor monotherapies over combinations in both academia & biotech. Given the inherent divide-and-conquer apporach of rejuvenation, this also makes slowing aging easier.
Thus it's understandable that more of the field (my vague sense is 2/3-ish) in both academia & biotech work primarily on slowing aging. But there's clearly much important work rightly classified as reversing accumulated changes, such as senolytics, removing misfolded proteins, replacing damaged tissue, lengthening telomeres, removing lipofuscin, breaking ECM crosslinks, & reseting epigenetic state (reprogramming).
But despite that the paradigm skew isn't 90/10 or more, some in the slow-aging part of the field often talk like the rejuvenation paradigmn doesn't exist or shouldn't. Examples: Some claim that reversing aging is impossible (presumably meaning that covering all the changes comprehensively is impossible since it seems self-evident at this point that some are clearly reversible, but I admit that I don't fully understand the claim of impossibility). Some claim that since the benefits of even just a couple years of healthspan extension in humans would bring such enormous benefits that we should focus all our attention on that. The ITP is held up as a gold standard and some have recently claimed it should be the primary way the field measures its own progress, but it's only really structured to test the slow-aging paradigm & just isn't set up to measure progress of incrementally more comprehensive piecemeal reversion. And Aubrey de Grey's many publications from the 2000s on the basic damage repair paradigmn that he labeled SENS were (inexplicably to me) omitted completely from even a mention in the (subsequently much loved) Hallmarks of Aging paper.
Slowing aging is great and may bring huge benefits to humanity (eg $38T in GDP for 1yr of healthspan extension by one analysis). Directly targeting the aging process(es) even to just slow them down is still much better than the current siloed disease-centric paradigmn of modern medicne (sickcare instead of healthcare). For these reasons I fully cheer such efforts & try to cover them as an important part of the field at AgingBiotech.info. But slowing aging still has inherent limitations. It brings more limited benefits to those who are already old whenever any new/improved intervention is introduced. It can never restore the full health of young adulthood to those already older than that. It requires constant dosing. And current evidence suggests that total human lifespan benefit will be only a small fraction of that achieved for shorter-lived species, and far less than 2x. Furthermore, there is little evidence so far that slow-aging interventions can do more than shift organisms within the range of aging rates achievable via lifestyle modification. (I claim that all age-slowing therapeutics should be tested pre-clinically against controls w/ lifestyle, at the very least total calories, optimized for lifespan in the same strain. Alas, this will inevitably reduce effect size and thus researchers, esp those trying to commercialize in biotech, are disincentized from doing so.)
Thus, my main goal (and the focus of my investing) is rejuvenation. Lifespan extension is only a side effect. My main goal is to get everyone back to the full health of young adulthood, the prime of life. Repeatedly. I'd like to see more open discussion in the field of why others favor age slowing vs reversal, and I'm going to increasingly start calling out any discussions of the field that I see that try to hide, ignore, or implicitly assume the non-existence of reverse-aging efforts.
Cat retweeted
🤩Turn Bio on Track to be First Longevity Company Taking Cell Rejuvenation Therapy to Clinic. 🤯
Turn Bio, a project backed with $1M by the VitaDAO community, receives positive FDA feedback on TRN-001 - a cell rejuvenation therapy.🧬
longevity.technology/news/wi…
Cat retweeted
1/ Announcing COHORT 3 of the Longevity Biotech Fellowship! ❤️🚀
Join the revolution to end aging - and get to work building a future where death and decline are optional.
Apply now: longbiofellowship.org/apply
⏳Deadline: Dec 31, Kickoff: Jan 18 ❄️
Cat retweeted
Saying forever in sign language!! @realNathanCheng ♾️ @catthu
Wrapped up filming Day 1 of the Longevity Zero to One Course with @catthu and Michael Florea!
Cat retweeted
I recently had the opportunity to interview @catthu from @vita_dao about the state of the art of longevity research and how DAOs can promote decentrilized science
🧵🧵🧵Here were my top takeaways🧵🧵🧵
open.spotify.com/episode/77Y…
Cat retweeted
🙌 A huge shout-out to the dedicated community members of VitaDAO!
@longevion
@MaxUnfried
@catthu
@vincentweisser
Their unwavering support for #Zuzalu and their contributions to all aspects of longevity research have truly made a difference.
vitadao.com/zuzalu
Cat retweeted
"Have you witnessed any cross-pollination between longevity and other fields?
The second cross-pollination event happened between the longevity people and people building new cities. There are people from @Prosperahn here, from @vita_dao, and now, they are working much more closely together than ever before."
Right on! @longevion @vincentweisser @catthu
Interview with @VitalikButerin about @vita_dao 's network state, #Zuzalu, which was focusing on #tech development, #AI, and --most importantly-- #healthspan, #lifespan, and reversing #aging.
lifespan.io/news/vitalik-but…
#NetworkState #Montenegro #crypto #cryptocurrency #eth #ethereum #dao #daos #vitadao #vita

























